(Q46580831)

23 December 2017

title

Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers (English)

1 reference

23 December 2017

0 references

9

Tom van der Poll

1 reference

23 December 2017

Nico A Maris

1

1 reference

23 December 2017

Alex F de Vos

2

1 reference

23 December 2017

Mark C Dessing

3

1 reference

23 December 2017

C Arnold Spek

4

1 reference

23 December 2017

Rene Lutter

5

1 reference

23 December 2017

Henk M Jansen

6

1 reference

23 December 2017

Jaring S van der Zee

7

1 reference

23 December 2017

Paul Bresser

8

1 reference

23 December 2017

language of work or name

English

0 references

publication date

30 June 2005

1 reference

23 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

23 December 2017

volume

172

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

878-884

1 reference

23 December 2017

Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

The current place of beta 2-agonists in the management of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

A new method for isolation of human lymphocyte subsets reveals differential regulation of beta-adrenergic receptors by terbutaline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Effect of beta-agonists on inflammatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

The duration of action of non-beta 2-adrenoceptor mediated responses to salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Salmeterol reduces early- and late-phase plasma leakage and leukocyte adhesion in rat airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Salmeterol, a beta2-receptor agonist, attenuates lipopolysaccharide-induced lung inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Grain dust and endotoxin inhalation challenges produce similar inflammatory responses in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Dose-response relationship to inhaled endotoxin in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Healthy subjects express differences in clinical responses to inhaled lipopolysaccharide that are related with inflammation and with atopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Local inflammatory responses following bronchial endotoxin instillation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Protein tyrosine phosphatases and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Anti-inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

The role of cyclic nucleotides in neutrophil migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Modulation of PMN-endothelial cells interactions by cyclic nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Pretreatment with ibuprofen augments circulating tumor necrosis factor-alpha, interleukin-6, and elastase during acute endotoxinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Inhibition of IFN-gamma induction of class II MHC genes by cAMP and prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

The inflammatory response in humans after inhalation of bacterial endotoxin: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

Participation of β-Adrenergic Receptors on Macrophages in Modulation of LPS-Induced Cytokine Release

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-451OC

10.1164/RCCM.200503-451OC

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

15994467

1 reference

23 December 2017